This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
By This Author:
Page 2 of 6

Molycorp: Hot, Trending, Speculative Play

By Jim Van Meerten

The rare-earth mining stock is suddenly in the news.

12:34PM 12/10/12

Time to 'Friend' Facebook

By Jim Van Meerten

After six months of trading the stock deserves a place on your watch list.

06:30AM 12/05/12

Big 5 Out Paces Competition

By Jim Van Meerten

On the heels of a strong earnings report, the sporting goods store is looking good.

03:57PM 11/15/12

Price Momentum Rises for Research in Motion

By Jim Van Meerten

Signs indicate pessimism may have depressed this stock more than it deserves.

02:55PM 11/13/12

Who'd Be Nuts Enough to Sell Apple?: Opinion

By Jim Van Meerten

I can't see any reason to sell this stock and I see every reason to have it on your watchlists and be prepared to hit the buy button at any moment.

12:40PM 11/09/12

Don't Dance, Sit This One Out

By Jim Van Meerten

The odds are not in your favor right now. So, have a seat.

09:53AM 11/08/12

Tenet Healthcare May Benefit From Obamacare

By Jim Van Meerten

If you're looking for a bullish stock play on Obama's election victory, Tenet Healthcare is it.

12:45PM 11/07/12

Expedia Winning the Travel Wars

By Jim Van Meerten

Tourist and business travel is increasing, and the online service is benefiting.

12:19PM 10/26/12

Markel Is a Great Choice for Long-Term Investors: Opinion

By Jim Van Meerten

Markel has solid projections for revenue and earnings, just what long-term investors need.

12:09PM 10/24/12

If You're Waiting for a Google Dip, Too Late

By Jim Van Meerten

Google still has solid fundamentals and strong earnings and revenue projections, making this a buying opportunity.

01:00PM 10/19/12

Page 2 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs